Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain ...

"The findings uncover a new way in which the immune system is suppressed, limiting T cells from fighting cancer spread. This ...

The anti-clotting effect of aspirin may trigger a biological chain of events that stops cancer cells from metastasizing, researchers say.

Through a mouse study, scientists have found that aspirin may help prevent metastases, or secondary tumors, by boosting the body’s immune response.

The new research suggests a path for aspirin to become a cancer treatment - but people are being warned not to start taking it daily without speaking to a doctor.

The scientists traced signals in the cell to determine that ARHGEF1 is switched on when T cells are exposed to a clotting factor called thromboxane A2 (TXA2). This was an unexpected revelation for ...

As researchers explain in a release from the University of Cambridge, aspirin can reduce a clotting factor known as thromboxane A2 (TXA2). But a side effect of this clotting factor is that it ...